These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36370104)

  • 1. Dietary Diindolylmethane Enhances the Therapeutic Effect of Centchroman in Breast Cancer by Inhibiting Neoangiogenesis.
    Penta D; Natesh J; Mondal P; Meeran SM
    Nutr Cancer; 2023; 75(2):734-749. PubMed ID: 36370104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary bioactive diindolylmethane enhances the therapeutic efficacy of centchroman in breast cancer cells by regulating ABCB1/P-gp efflux transporter.
    Penta D; Mondal P; Natesh J; Meeran SM
    J Nutr Biochem; 2021 Aug; 94():108749. PubMed ID: 33910062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis.
    Dewangan J; Kaushik S; Rath SK; Balapure AK
    Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diindolylmethane Promotes Metabolic Crisis and Enhances the Efficacy of Centchroman in Breast Cancer: A
    Penta D; Tripathi P; Rajarajan D; Natesh J; Mondal P; Meeran SM
    ACS Omega; 2022 Nov; 7(47):43147-43160. PubMed ID: 36467932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis.
    Khan S; Shukla S; Farhan M; Sinha S; Lakra AD; Penta D; Kannan A; Meeran SM
    Life Sci; 2020 Sep; 256():117976. PubMed ID: 32561397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling.
    Khan S; Shukla S; Sinha S; Lakra AD; Bora HK; Meeran SM
    Int J Biochem Cell Biol; 2015 Jan; 58():1-16. PubMed ID: 25448414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGFa/VEGFR2 autocrine and paracrine signaling promotes cervical carcinogenesis via β-catenin and snail.
    Prasad CB; Singh D; Pandey LK; Pradhan S; Singh S; Narayan G
    Int J Biochem Cell Biol; 2022 Jan; 142():106122. PubMed ID: 34826615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
    Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
    Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer.
    Li Z; Liu Q; Cai Y; Ye N; He Z; Yao Y; Ding Y; Wang P; Qi C; Zheng L; Wang L; Zhou J; Zhang QQ
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167114. PubMed ID: 38447883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.
    Sinha S; Khan S; Shukla S; Lakra AD; Kumar S; Das G; Maurya R; Meeran SM
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):41-56. PubMed ID: 27210504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centchroman altered the expressions of tumor-related genes through active chromatin modifications in mammary cancer.
    Khan S; Shukla S; Sinha S; Meeran SM
    Mol Carcinog; 2016 Nov; 55(11):1747-1760. PubMed ID: 26465660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of tumor growth and angiogenesis in triple-negative breast cancer by using redox nanoparticles.
    Shashni B; Nishikawa Y; Nagasaki Y
    Biomaterials; 2021 Feb; 269():120645. PubMed ID: 33453633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3'-diindolylmethane.
    Chang X; Firestone GL; Bjeldanes LF
    Carcinogenesis; 2006 Mar; 27(3):541-50. PubMed ID: 16199440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway.
    Wang Z; Wang N; Han S; Wang D; Mo S; Yu L; Huang H; Tsui K; Shen J; Chen J
    PLoS One; 2013; 8(7):e68566. PubMed ID: 23861918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers.
    Di Mauro C; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Formisano L; De Falco S; Cicatiello V; Di Bonito M; Cantile M; Collina F; Chambery A; Veneziani BM; De Placido S; Bianco R
    Br J Cancer; 2017 May; 116(11):1425-1435. PubMed ID: 28441382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells.
    Jiang F; Li Y; Si L; Zhang Z; Li Z
    Cell Biol Toxicol; 2019 Aug; 35(4):361-371. PubMed ID: 30612216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
    Shin SU; Cho HM; Das R; Gil-Henn H; Ramakrishnan S; Al Bayati A; Carroll SF; Zhang Y; Sankar AP; Elledge C; Pimentel A; Blonska M; Rosenblatt JD
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
    Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
    J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer.
    Lee GA; Hwang KA; Choi KC
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.